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Abstract
Chronic liver disease at initial stages often occurs with no symptoms or with 
very non-specific symptoms, so timely diagnosis of chronic liver disease is of great 
importance, and there are significant difficulties involved therein. Not being able to 
diagnose the hepatic disease early, difficulties with the management of the disease 
and treatment arise. Different aspects of the clinical and laboratory evaluation may 
be of assistance in providing an early diagnosis, ranging from laboratory tests, to 
ultrasound, to EGD, and to rheohepatography (not used that frequently) among 
others. Stages of hepatitis affect the hepatic and general symptoms, and morpho-
logical changes in liver tissue are presented and discussed, followed by a section 
devoted to hepatic encephalopathy (HE) and how it is influenced by cerebral 
hemodynamics and state of liver cirrhosis (LC).
Keywords: liver, chronic hepatitis, liver cirrhosis, chronic diffuse liver disease, 
hepatic encephalopathy
1. Introduction
Chronic hepatitis (CH) and liver cirrhosis (LC), especially the latter, are the 
most common cause of portal hypertension (PH), leading to changes in the func-
tional ability of the affected organ, which is manifested by corresponding changes 
in blood biochemical parameters. At the same time, among the many clinical 
manifestations of the disease, there is no symptomatology pathogenic for these 
conditions, which allows for a timely diagnosis. That leads to the difficulties of early 
detection of the transition of the inflammatory process of the liver to the cirrhosis, 
and the possibility of initiating timely treatment.
In patients of different age groups with liver cirrhosis of viral etiology of classes 
A, B, and C according to Child-Pugh, chronic hepatic encephalopathy of all stages 
can occur against the background of dyscirculatory disorders with the develop-
ment of chronic cirrhosis (LC) with the rapid disability of patients. In recent 
decades, studies have been conducted on the effect of LC on the severity of hepatic 
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encephalopathy (HE), etiology, stages of the disease, and psychological character-
istics of the personality [1–4]. In modern approaches to the treatment of LC, it is 
necessary to take into account the etiological factor, the reduction of pathogenetic 
reactions that support the activity of the process, prevention of progression of 
cirrhosis, treatment of symptoms, and complications of the disease such as portal 
hypertension, HE, ascites, ascites-peritonitis, and hepatorenal syndrome. HE can 
be subclinical in nature, and mortality among patients is up to 10% and is mostly 
associated with comorbidities, and not with complications of portal hypertension 
[5–8]. Therefore, the assessment of the degree of HE and the corresponding indi-
vidualized approach to each patient in terms of the selection of therapy can signifi-
cantly reduce its stage, which also improves the quality of life of patients [9, 10]
1.1 Materials and research methods
The most common methods of laboratory diagnosis of chronic diffuse liver dis-
ease (CDLD) are biochemical analysis of blood, the study of coagulation with the 
assessment of coagulation, anticoagulation systems, and special tests to determine 
some of the complications of the underlying disease. The case of active and com-
plicated course of the disease can be obtained from a general blood test. Indicators 
of coagulation and blood rheology are important, excluding in the postoperative 
period a number of serious complications due to impaired microcirculation can 
develop and including acute hepatocellular insufficiency, gastrointestinal bleeding, 
and even with inactive liver cirrhosis.
1.2 Materials and research methods used for assessing hepatic encephalopathy
One hundred seven patients (87 (81.3%) men and 20 (18.7%) women) with  
viral etiology LC were examined: HBV infection (n = 35.1%), HCV infection  
(n = 46.1%), and infection HBV + HCV (n = 18.8%) aged from 30 to 69 years 
(average age was 57.3 ± 4.6 years). According to the compensation stages by Child-
Pugh LC, the patients were divided into three groups: the first group (n = 35) 
consisted of Class A LC patients, the second group (n = 37) consisted of Class B 
patients, and the third group (n = 35) included patients with Class C LC. To con-
firm the diagnosis of LC and its etiology and stage of compensation and complica-
tions, the clinical picture and history of the disease were studied; a complex of 
clinical, laboratory and instrumental diagnostic methods was conducted. To match 
the fibrosis index and the LC for METAVIR and ISHAK, a classification counting 
scale (Bonacini) was used. Patients with cardiac arrhythmias and hormonal status 
were excluded from the study, without heart defects and an increase in blood pres-
sure above stage III.
Clinical diagnosis of HE, assessment of its severity, and basic and additional 
instrumental studies were conducted in accordance with the recommendations of 
the working group of the 11th World Congress of Gastroenterologists. Evaluation 
of the stages of HE was carried out according to a descriptive scale of West-Haven 
symptoms and Reitan test (number connection test). Ultrasound diagnosis of 
cerebral hemodynamics was performed using the PHILIPS EPIQ 7G ultrasound 
machine (USA) using the W. J. Zwiebel, J. S. Pellerito method (2010). Diagnostics of 
brain blood flow included the study of blood flow parameters in the internal carotid 
(ICA) and middle cerebral arteries (MCA) of the first order of both hemispheres, 
maximal, minimal, and average BFV; contralateral asymmetry of the mean BFV; 
carbon-dependent blood flow indicators (RI and PI); cerebral perfusion pressure; 
reactivity of blood flow; cerebrovascular blood reserve; cerebrovascular reactiv-
ity index; and vasomotor reactivity, were determined by the functional reserve of 
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the connecting arteries of the circle of Willis Matas sample. To study the function 
of the heart in LC, echocardiography was performed in the M-modal and two-
dimensional modes according to the standard method of the American Association 
of Echocardiography. In 15.9% of cases, autopsy material served as the object of 
research of the abdominal cavity and brain. For the differential diagnosis of LC and 
its complications, CT, MRI, FGDS, Reitan’s combination test, and electroencepha-
lography were performed.
The study of the parameters of cerebral hemodynamics with LC of classes A, B, 
and C consisted of several stages. At the first stage, the parameters of central hemo-
dynamics were studied. The central element in this question was the study of the 
systolic function of the left ventricle. At the second stage, the parameters of cerebral 
hemodynamics were studied. The results of the average values of blood flow param-
eters and intima-media complex (IMC) thickness in the internal carotid arteries with 
LC of classes A, B, and C were analyzed. In addition, the presence of hemisphere 
asymmetry was associated with the development of dyscirculatory disorders, con-
firmed by neuroimaging and autopsy of the brain. Thus, in the prospective observa-
tion, the autopsy material of the brain served as confirmation of the comorbidity of 
HE and dyscirculatory disorders from minimal to irreversible with the LC.
All patients with clinical and instrumental signs of chronic HE and cerebrovas-
cular insufficiency were given a psychometric test of Reitan for the connection of 
numbers.
Processing of the obtained clinical and laboratory and instrumental data was 
carried out using the criteria of parametric and nonparametric statistics. The 
magnitude of the distribution of the Gauss density was estimated from the values of 
the interquartile range. The correlation matrix method was used to determine the 
degree of interrelation between individual signs. Statistical processing of the mate-
rial obtained was carried out using the program Stat Soft Statistica, version 10.0.
2. Chronic hepatitis of minimal activity
The clinical picture of patients with minimal activity CH was characterized by a 
paucity of symptoms. The majority of patients (21) had an asymptomatic course of 
the disease. The admission of patients to the hospital was associated with symptoms 
of chronic cholecystitis or the presence of changes in the biochemical blood tests 
detected during the preventive examination. In some cases, treatment was associ-
ated with the appearance of some symptoms of asthenic and dyspeptic syndrome in 
individuals who considered themselves practically healthy. However, some patients 
complained of weakness (31.4%) and nausea (23.4%).
Careful collection of anamnesis showed that 66.2% (131) of the patients previ-
ously had AVH, 15.6% (31) had contact with patients with AVH, 12.1% (24) shortly 
before the disease underwent surgery and blood transfusion or long-term (more 
than 1 month) received intramuscular injections, and only 12 patients pointed to 
alcohol abuse.
In patients with chronic hepatitis (Tables 1 and 2), with minimal degree of 
activity, no statistically significant expansion of the diameter and cross-sectional 
area of the portal and splenic veins was compared with the control group.
There were also no statistically significant changes in the maximum and volu-
metric blood flow velocities through the portal and splenic veins with pulsed-wave 
Doppler sonography.
An increase in portal pressure primarily affects the volume velocity of the blood 
flow in the portal and then in the splenic veins, depending on its size. So, at the level 
of portal pressure up to 128.3–134.3 mm H2O, a further increase in pressure in the 
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portal vein to 140.3–146.3 mm H2O leads to initial changes in hemodynamics in the 
splenic vein.
Echographic signs of chronic cholecystitis with calculi of various sizes were 
found in 51.5% of patients.
CT scan, performed in 15.2% of patients, also showed no changes in the liver, 
with the exception of 60% of patients with chronic cholecystitis, where gallbladder 
calculi were visualized.
Radiocontrast study in eight (24.2%) patients revealed a diffusely uneven 
distribution of radiopharmaceuticals in the liver at normal sizes and even and clear 
contours of the organ.
Esophagogastroduodenoscopy in 24.4% of patients found superficial, in 21.2% 
atrophic, and in 3% subatrophic gastritis, in 21.2% duodenitis, in 12% duodenogas-
tric, and in 15% gastroesophageal reflux, in some cases with erosive esophagitis.
Thus, the clinical diagnosis of minimal activity CH is based on a thorough col-
lection of anamnesis, clarification of complaints, clinical symptoms, and laboratory 
data, which allows to establish a clinical diagnosis and determine the tactics of 
further research and treatment by the first day after admission. The information 
content of noninvasive additional research methods in patients of this group is 
Indicators CH of minimal activity (n = 207) M ± SD in patients of 
control group (n = 40)
р
Limits of 
variation
M ± SD
Inner diameter, mm 6.0–8.0 6.63 ± 0.69 6.41 ± 0.61 >0.05
Cross-sectional area, 
sq. cm.
0.28–0.51 0.37 ± 0.02 0.33 ± 0.02 >0.05
Max BFV, cm/s 17.0–22.2 18.94 ± 0.97 19.22 ± 2.23 >0.05
BVF, ml/min. 274.3–539.6 379.51 ± 74.33 345.41 ± 34.62 >0.05
p—Statistical significance of the difference between control group and patients with chronic hepatitis.
Table 2. 
Results of hemodynamic studies in the splenic vein with chronic hepatitis of minimal activity (M ± SD).
Indicators CH of minimal activity (n = 207) M ± SD in patients of 
control group (n = 40)
р
Limits of 
variation
M ± SD
Inner diameter, mm 9.0–13.0 10.71 + 1.25 10.22 + 0.71 >0.05
Cross-sectional 
area, sq. cm.
0.64–1.33 0.91 ± 0.05 0.83 ± 0.03 >0.05
Max BFV, cm/s 18.2–25.0 21.63 ± 1.56 21.63 ± 2.71 >0.05
BVF, ml/min. 686.3–
1910.3
1161.91 ± 341.19 1075.8 ± 83.61 >0.05
Portal vein pressure, 
mm H2O
98.3–164.3 123.3 ± 10.49 113.0 ± 4.41 >0.05
p—Statistical significance of the difference between control group and patients with chronic hepatitis.
Table 1. 
Results of hemodynamic studies in the portal vein in patients with chronic hepatitis of minimal activity 
(M ± SD).
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extremely low. In this regard, morphological study is the most objective and infor-
mative diagnostic method.
A histological study conducted in 16 patients showed that 12 of them have a 
morphological picture of chronic persistent hepatitis, including 7 patients with 
chronic calculous cholecystitis.
Biopsy in this category of patients is very problematic, due to the frequent rejection 
of patients from the study, due to the invasiveness of the technique. At the same time, 
we consider it unnecessary to conduct histological studies on a universal basis, limiting 
the indications for its implementation only to those who need histological monitoring 
of the effectiveness of the treatment or surgical intervention, due to the long-term, 
uncorrected conservative therapy, and activation of the pathological process in the 
liver. In other cases, the activity of the pathological process should be determined by 
the level of transaminases (an increase in the ALT level to three norms).
3. Chronic hepatitis of moderate activity
The clinical manifestation in 39 patients with moderately active chronic hepa-
titis was different from the previous group by more intense symptoms than in the 
previous group. Most patients (30) were admitted to the clinic due to the existing 
symptoms of abdominal pain and dyspeptic, asthenic, and hemorrhagic syndromes. 
Twenty-three patients complained of pain (9) and severity (14) in the right hypo-
chondrium, especially after an error in diet or exercise. In nine of them, the pain 
was paroxysmal. Six patients indicated nausea and vomiting (3) after ingestion of 
fatty foods, 7 patients indicated disorders of the stool, 6 patients indicated irritabil-
ity, 14 patients indicated weakness, 7 patients indicated decreased performance, 
and 3 patients indicated bleeding from the nose and gums.
According to case records it turned out that 15 patients had previous AVH, 3 
of them received hormonal therapy due to severe disease, 5 pointed to jaundice of 
unknown etiology, 6 contact with AVH patients, and 4 undergone surgery, blood 
transfusion, or prolonged (up to 1 month) intramuscular injections.
The general condition was assessed in 25 patients as satisfactory and in 14, mod-
erate. Reduced nutrition occurred in 15 patients, single telangiectasia on the upper 
half of the chest in 4 patients. Yellow skin extinguishing and icteric sclera were 
observed in eight, palmar erythema in five patients. Visually abdominal distension 
was determined in four patients. On palpation, in 26 patients, an enlarged liver was 
protruded, projecting 2–3 cm from under the edge of the right costal arch. In 23 of 
them its compaction and tenderness was determined. The spleen in six patients was 
slightly enlarged; its lower pole was felt at the edge of the left costal arch without 
any subjective sensations.
Hypochromic anemia of grade 1 occurred in grade 7, grade 2, and grade 6, 
moderate transient thrombocytopenia in seven, and accelerated ESR in 22 patients. 
However, when recalculating the peripheral blood indices for the total number 
of patients with moderately active chronic gastritis, a moderate decrease in the 
number of red blood cells was obtained with relatively normal values of other 
peripheral blood indices. Evaluation of the functional state of the liver using a 
complex of biochemical research methods showed the depression of its function, 
which was expressed by a significant increase in bilirubin (58.1 ± 1.4 mmol/l) 
fractions of aminotransferases more than three standards (ALT, 2.27 ± 0.06; AST, 
1.17 ± 0.06 mmol/h l). Dysproteinemia was observed (albumin 49.1 ± 0.89% and 
globulins 23.3 ± 0.35%), with a decrease in albumin/globulin coefficient (A/G ratio) 
to 0.96, with relatively normal indicator total protein levels.
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In patients with chronic hepatitis of moderate degree of activity, the contours of 
the liver were even in only 154 (74.4%) patients, and the pointed edge of the liver 
was found in 169 (81.6%) patients. The echogenicity of the parenchyma is irregu-
larly increased in 197 (80.7%) patients. In 143 (69.1%) patients, the phenomenon 
of “distal attenuation” of ultrasound was observed, while the oblique size of the 
right lobe of the liver was more than 160 mm. In addition, 28 (13.5%) patients with 
chronic hepatitis had abdominal lymphadenopathy at the gate of the liver.
In patients with chronic hepatitis of moderate activity of the inflammatory 
process (Tables 3 and 4), expansion of the portal vein diameter and, accord-
ingly, an increase in its cross-sectional area against a background of pressure 
increase in it were noted. At the same time, there was no statistically significant 
increase in the internal diameter and cross-sectional area of the splenic vein; 
although in some patients, there was a change in both signs indicating increased 
portal pressure.
Doppler study of the blood flow in the portal vein did not show a statistically 
significant decrease in the maximum and increase in the volumetric flow rate. 
From the data presented in Table 4, it is also clear that signs of hemodynamic 
disturbances are observed in the splenic vein, which coincide in their direction 
with those in the portal vein, but quantitatively these changes are not so signifi-
cant (p > 0.05).
Indicators CH of moderate activity (n = 23) M ± SD in patients of control 
group (n = 40)
р
Limits of 
variation
M ± SD
Inner diameter, mm 6.0–9.0 7.11 ± 0.83 6.4 ± 0.61 >0.05
Cross-sectional 
area, sq. cm.
0.28–0.64 0.41 ± 0.03 0.33 ± 0.02 >0.05
Max BFV, cm/s 15.2–20.1 17.81 ± 0.94 19.2 ± 2.23 >0.05
BVF, ml/min. 280.2–608.3 402.01 ± 84.41 345.4 ± 34.62 >0.05
p—Statistical significance of the difference between control group and patients with chronic hepatitis.
Table 4. 
Results of hemodynamic studies in the splenic vein in patients with chronic hepatitis of moderate activity 
(M ± SD).
Indicators CH of moderate activity (n = 23) M ± SD in patients of 
control group (n = 40)
р
Limits of 
variation
M ± SD
Inner diameter, mm 11.0–14.0 12.81 ± 1.11 10.2 ± 0.71 <0.05
Cross-sectional area, 
sq. cm.
0.95–1.54 1.29 ± 0.04 0.83 ± 0.03 <0.05
Max BFV, cm/s 16.1–23.2 18.92 ± 1.72 21.6 ± 2.71 <0.05
BVF, ml/min. 686.7–1898.1 1257.51 ± 355.23 1075.8 ± 83.61 <0.05
Portal vein pressure, 
mm H2O
145.6–190.9 164.4 ± 9.34 113.0 ± 4.41 <0.05
p—Statistical significance of the difference between control group and patients with chronic hepatitis.
Table 3. 
Results of hemodynamic studies in the portal vein in patients with chronic hepatitis of moderate activity 
(M ± SD).
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It is noted that the increase in portal pressure to the level of 170.3–174.4 mm H2O 
led to changes in hemodynamic parameters: diameter and linear and volumetric 
blood flow velocity in the portal vein. A further increase in portal pressure to 
178.4–182.6 mm H2O influenced the change in the above parameters of hemody-
namics in the splenic vein. First of all, these changes concerned the diameter of the 
portal vein and the volumetric blood flow in the hepatoportal bed.
CT, as well as in the previous group of patients, was performed in a limited 
number of 42 patients (20.3%). In the study in addition to moderate hepatomegaly, 
changes in the parenchyma of the liver were not found. In 32 cases, along with an 
increase in the size of the liver, concrements of the gallbladder were detected.
Radiocontrast study performed in 39% of patients revealed a moderate increase 
in the size of the liver and, in 82% of cases, a diffuse decrease in the accumulative 
function of the organ. In 5% of cases there was a redistribution of the radiopharma-
ceutical in the spleen.
EGD was performed in 149 (72%) patients; in 69 of them inflammatory, changes 
of the upper digestive tract were found in the form of superficial (32), erosive 
gastritis, duodenitis (32), duodenogastric (1), and gastroesophageal (4) reflux.
Thus, patients with chronic hepatitis of moderate activity are characterized by 
the presence of more constant clinical and laboratory changes that characterize the 
patient’s true state. In a similar situation, conducting additional noninvasive research 
methods (ultrasound and radiocontrast study) allows a certain part of patients to 
reveal data (a uniform increase in the size of the liver, changes in the parenchyma of 
the organ) characterizing the morpho-functional state of the affected organ.
Histological studies of liver tissue carried out in 28 patients, in order to detect 
the morphological state of the liver; 61% of the examined patients found a picture 
of chronic persistent (CPH), and 39% had chronic active hepatitis (CAH).
Morphological studies of patients with chronic CH activity are not only diagnos-
tic and diagnostic but also tactical. More than 1/3 of the patients in this group have 
a histological picture of CAH, in which the treatment tactics is somewhat different 
than with CPH. Therefore, for the development of a pathogenetic-based surgical 
tactics for chronic hepatitis C, we consider it expedient to perform not only intraop-
erative but also preoperative liver biopsy.
4. Chronic hepatitis of severe activity
This group consisted of 171 patients with the most prominent clinical symptoms 
of severe disease. Complaints and manifestations of the disease included almost the 
entire clinical syndromology of CDLD. The majority of patients (84.2%) complained 
of pain or heaviness in the right hypochondrium and epigastrium (abdominal pain 
syndrome); 63.2% of patients complained of weakness and fatigue; 47.4% - reduction 
of working ability (asthenic syndrome); 58% - loss of appetite; 21% - weight loss; 21% - 
nausea; 15.8% -  disorders of the stool and flatulence (dyspeptic syndrome); 15.8% -  
jaundice; 15.8% - pruritus; 15.8% - dark urine; 10.5% - bleeding from the nose and 
gums; 5.3% - subcutaneous hemorrhages; 5.3% -  menorrhagia; 10.5% - dysmenorrhea 
(endocrine syndrome); 15.8% - increase in the size of the abdomen and decreased 
diuresis; 10.5% - leg swelling (edema-ascitic syndrome); 10.5% - by memory loss, 
drowsiness, and periods of disorientation in time and space; and 5.3% - improper 
behavior (encephalopathy syndrome). In 26.3% of patients, the appearance of the 
above complaints was accompanied by an increase in body temperature to 38–39°C.
Anamnestic data showed that 90 patients in the period from 4 months to 11 
years ago had AVH, 18 of them received hormonal (prednisolone) therapy due to 
severe disease, 18 indicated episodes of jaundice of unknown etiology, 36 on contact 
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with AVH patients, 18 for previous surgical interventions with transfusion of donor 
blood or long-term infusion and injection therapy, and 9 for taking antituberculosis 
drugs (rifampicin, isoniazid, streptomycin, and analogues of these drugs) for 1 year 
or more, according to suspected pulmonary tuberculosis.
Condition of 18 patients at admission to the clinic is regarded as satisfactory, 126 
moderate, and 27 severe. Severity of the condition was due to the course of the under-
lying disease, as well as secondary changes from other organs. Severe jaundice occurred 
in 27 patients; in 9 of them with subcutaneous hemorrhages; in 18 patients with telan-
giectasias on the skin of the chest, shoulders, and face; and in 9 patients with urticaria 
on the face and neck. Yellowness of the skin and sclera was detected in 45 patients. And 
at 18 it was accompanied by skin itch, as evidenced by the traces of scratches that were 
present in these patients. Palmar erythema was found in 30 patients. Nutrition in 42 
patients was reduced, and in 27 patient, there was pronounced weight loss. However, 
only nine patients indicated weight loss during the last 6 months.
According to 45 patients auscultation data, systolic murmur at the apex of 
the heart and at the Erb’s point was heard. A moderate increase in the abdomen 
occurred in 36 patients. On palpation, 108 patients had hepatomegaly, and in 26 of 
them, the lower edge of the liver protruded more than 5 cm from under the edge of 
the right costal arch (along the midclavicular line to the right). The edge of the liver, 
as a rule, is rounded, the surface is smooth, and tissue is somewhat thickened and 
painful. In 18 cases, an enlarged, painful, slightly tense gallbladder was palpable. 
In 36 patients enlarged spleen was determined, tissue being compacted and painful 
on palpation. In 18 of them, the lower pole of the organ emerged from under the 
edge of the left costal arch by 3–5 cm and in 9 by more than 6 cm. Free fluid in the 
abdominal cavity was detected in 11 patients with a severe course of the pathologi-
cal process.
Patients in this group had hypochromic anemia, moderate thrombocytopenia 
(platelets less than 200,000), and accelerated ESR. Liver function was character-
ized by severe hyperbilirubinemia (total of 74.2 ± 8.2 mmol/l), mainly due to the 
direct fraction (49.7, 1.9), increased transaminase levels (AlAT, 2.67±0, 12; AsAT, 
1.6 ± 0.15 mmol/h l), and in 7 (21%) dysproteinemia in the form of hypoalbuminemia 
(45.8 ± 0.53%) and hypergammaglobulinemia (25.9 ± 0.4%). Thymol test result 
tended to increase (9.0 ± 0.5 units), reaching 31 units in severe patients.
Ultrasound examination in all patients of this group revealed an increase in the 
size of the liver compared with the data of the previous group (Table 5). In patients 
with chronic hepatitis of high activity in 64 (37.4%) patients, the contours of the 
liver were lightly wavy; in 54 (31.6%) the edge of the liver was rounded. In 153 
(89.5%) patients, the echogenicity of the liver parenchyma was unevenly elevated. 
The phenomenon of “distal attenuation” of ultrasound was detected in 134 (78.4%) 
patients, while the oblique size of the right lobe of the liver was more than 180 mm. 
In addition, 49 (28.78%) patients had lymphadenopathy in the gates of the liver, 
and 11 (6.4%) patients had a small amount of free fluid in the abdominal cavity, 
indicating the development of portal hypertension in these patients, which is not 
rare. It happens with the so-called “active” hepatitis at the height of the clinical and 
morphological manifestations of the disease.
A statistically significant enlargement of the liver in comparison with the 
control group was observed due to the total liver lobes: right to 186.13 ± 7.45 mm and 
90.61 ± 6.81 mm and the caudate to 24.36±1.43 mm. The area of the spleen in this 
group of patients was up to 40.93±1.99 sq. cm.
Results presented in Tables 6 and 7 rather convincingly indicate that patients 
with chronic hepatitis of a high degree of inflammatory activity show significant 
disorders of hepatic hemodynamics, manifested by a relatively high level of portal 
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pressure and dilatation of the portal and splenic veins without changing the velocity 
parameters of blood flow in them.
It is noted that the increase in portal pressure to the level of 185.5–197.2 mm H2O 
leads to a change in hemodynamic parameters: diameter and linear and volumetric 
blood flow velocity in the portal (mainly) and splenic veins. At first, volumetric 
blood flow velocity increases due to pressure in the above veins.
Thus, in patients with chronic hepatitis, there were changes in the echographic 
parameters of the liver and spleen, as well as the parameters of portal hemodynam-
ics, depending on the degree of development of the cytolytic syndrome.
Radiocontrast study performed in 108 patients found an increase in the size of 
the liver, and in 9 of them there was a diffuse uneven accumulation of radiopharma-
ceuticals in the liver and its redistribution into the spleen (in 36). In 45 cases, these 
changes are estimated as CH transition to liver cirrhosis.
Indicators
Size, mm
CH of severe activity (n = 23) M ± SD in patients of 
control group (n = 40)
р
Limits of 
variation
M ± SD
Liver
Oblique size of the right lobe 120.0–
205.0
186.13 ± 7.45 137.81 ± 1.79 >0.05
Anteroposterior size of the 
left lobe
66.0–114.0 90.61 ± 6.81 55.72 ± 1.87 >0.05
Anteroposterior size of the 
caudate lobe
21.0–30.0 17.63 ± 1.8 17.63 ± 1.83 >0.05
Spleen
Area, sq. cm 31.9–45.1 40.93 ± 1.99 31.84 ± 1.49 >0.05
p—Statistical significance of the difference between control group and patients with chronic hepatitis.
Table 5. 
Liver and spleen dimensions in patients with chronic hepatitis of severe activity (M ± SD).
Indicators CH of severe activity (n = 23) M ± SD in patients of 
control group (n = 40)
р
Limits of 
variation
M ± SD
Inner diameter, mm 12.0–15.0 13.79 ± 1.01 10.22 ± 0.71 >0.05
Cross-sectional area, 
sq. cm.
1.13–1.77 1.51 ± 0.06 0.83 ± 0.04 >0.05
Max BFV, cm/s 15.1–20.0 17.33 ± 1.33 21.63 ± 2.71 >0.05
BVF, ml/min. 772.3–
1863.9
1327.73 ± 315.81 1075.81 ± 83.61 >0.05
Portal vein pressure, 
mm H2O
169.9–212.4 193.4 ± 9.47 113.0 ± 4.41 >0.05
p—Statistical significance of the difference between control group and patients with chronic hepatitis.
Table 6. 
Results of hemodynamic studies in the portal vein in patients with chronic hepatitis of severe activity 
(M ± SD).
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EGD in 153 patients found inflammatory changes in the esophagus, stomach, 
and duodenum. At the same time, 18 of them revealed superficial, 72 erosive gastri-
tis, 27 duodenitis, 36 duodenogastric, 27 duodenogastric, and 77 gastroesophageal 
refluxes; 27 patients with this group showed varicose veins of the lower third of the 
esophagus grades I–II.
A pronounced clinical manifestation of the disease allows a more correct 
assessment of the patient’s condition and a correct preliminary diagnosis and 
determination of the correct diagnostic and therapeutic tactics. Ultrasound, 
radiocontrast study, and EGD in patients with chronic hepatitis of severe activity 
show an important diagnostic value and make it possible to identify some signs of 
a complicated course of the disease, which are not determined in a routine clinical 
study. Radiocontrast study in five patients, long before the liver biopsy, established 
signs of transition of CH to cirrhosis.
Pre- and intraoperative morphological studies of the liver in 16 patients of this 
group, in 7% of cases, established a histological picture of CPH, in 82% CAH, and 
in 11% CAH with transition to LC.
Thus, in the diagnosis of chronic hepatitis of severe activity, great importance, 
in addition to clinical, laboratory, and morphological data, is acquired by using 
modern noninvasive research methods, which provide sufficient information for 
correct diagnosis. In our opinion, in the diagnosis of CH of severe activity, it is 
necessary to give preference to noninvasive ultrasound and radiocontrast methods 
and resort to the use of invasive (biopsy, laparoscopy, etc.) ones only in exceptional 
cases, because any active interventions in this category of patients can lead to 
decompensation of the disease.
5.  Cerebral hemodynamic influence on the current and prediction of 
hepatic encephalopathy
In recent decades, studies have been conducted on the effects of cirrhosis of the 
liver (LC) on the severity of chronic hepatic encephalopathy (HE), etiology, stage, 
and psychological characteristics of the personality [11–14]. HE can be subclinical, 
and the mortality rate among patients is up to 10% and is mostly associated with 
comorbidities, and not with complications of PG [15–18]. That is why the assess-
ment of the degree of HE and the corresponding individualized approach to each 
patient in terms of the selection of therapy can significantly reduce the degree of 
encephalopathy, which also improves the quality of life of patients [19, 20]. In many 
pathological conditions, the occurrence of encephalopathy signals a disorder of 
brain metabolism, based on the formation of which is a violation of the blood-brain 
Indicators CH of severe activity (n = 23) M ± SD in patients of control 
group (n = 40)
р
CI (25–75%) SD
Inner diameter, mm 7.0–10.0 8.06 ± 0.91 6.41 ± 0.61 >0.05
Cross-sectional 
area, sq. cm.
0.44–0.81 0.59 ± 0.06 0.33 ± 0.02 >0.05
Max BFV, cm/s 15.1–19.02 16.78 ± 0.90 19.22 ± 2.23 >0.05
BVF, ml/min. 307.26–69,631.9 453.96 ± 99.08 345.41 ± 34.62 >0.05
p—Statistical significance of the difference between control group and patients with chronic hepatitis.
Table 7. 
Results of hemodynamic studies in the splenic vein in patients with chronic hepatitis of severe activity 
(M ± SD).
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barrier, the action of toxic substances, cerebral ischemia, cerebral hypoxia, the 
formation of endotoxins, and neurotransmitter disorders. In most cases, there is a 
combination of several pathophysiological mechanisms. And those, in turn, may 
lead to clinical picture of encephalopathy with cognitive, emotional, and motor 
impairment. However, despite numerous experimental and clinical studies of HE, 
the mechanism of its development remains controversial and controversial [21–24]. 
The purpose of this study is to assess the characteristics of cerebral hemodynam-
ics in the extra- and intracranial sections with LC of viral etiology of classes A, B, 
and C according to Child-Pugh to improve the optimization of early diagnosis of 
complications of encephalopathy at various stages of its development.
It has been established that with an increase in the stage of hepatic encephalopa-
thy, an increase in hemispheric asymmetry of blood flow in the middle cerebral 
arteries and in the time of the Reitan test is observed. The minimum time for 
connecting numbers during the test was noted at stage 1 of HE without comorbidity 
with circulatory encephalopathy (DE), the maximum with HE stage 3 in combina-
tion with DE stage 3.
Matrix analysis showed that, first, with an increase in the stages of hepatic 
encephalopathy, a statistically significant increase in the time to perform the Reitan 
test was observed. Secondly, the influence of the DE stages on the course of the 
HE stages is ambiguous, the minimum during stage I of the HE and the maximum 
with the HE of stage III. Thus, a statistically significant increase in the time of 
the Reitan test is recorded at stage I HE only in combination with stage III DE, at 
stage II HE, stage III DE, and stage III HE with any stage DE. When studying the 
characteristics of the relationship between the hemispheric asymmetry of the BFV 
in the MCA and the stages of HE, it was found that there is a fairly clear correlation 
between the hemisphere asymmetry of the blood flow in the MCA and the stages of 
the HE. Thus, with increasing stage of HE, hemispheric asymmetry of blood flow 
in MCA increases: the smallest hemisphere asymmetry of blood flow in MCA is 
observed with LC with clinical manifestations of HE of stages I–II and the greatest 
with HE of stages III–IV.
From the obtained results, it follows that the change in cerebral hemodynam-
ics in patients with LC is noted already at the level of the extracranial section of 
the carotid arteries. The presence of age-related changes in the arteries, such as 
intimal thickening before the formation of atherosclerotic plaques of different 
height and length with the formation of stenosis, tortuosity of the vessels led to 
hemisphere asymmetry of blood flow in them from 25.1 ± 2.42 to 39.5 ± 7.94% 
with the dynamics of the statistical significance of this parameter in comparison 
with the norm from p = 0.006936 to p = 0.000003 for LC of classes A and C, 
respectively.
Functional disorders of cerebral hemodynamics at the level of the intracranial 
section manifested changes in blood flow velocity characteristics, lability of vas-
cular resistance indices, hemispheric asymmetry of the blood flow, and decrease 
in the functional reserve of the connective arteries of the Willis circle. Against 
the background of atherosclerotic changes in the vascular wall and the lability of 
vascular resistance, there were large variations in the interquartile ranges of the 
velocity parameters of the blood flow and hemisphere asymmetry in the MCA 
with a general tendency of their medians to increase, which did not contradict the 
studies of other authors [25]. So, depending on the stage of compensation of the 
LC, there was a general tendency for the ACK (max) to increase from 110.7 ± 9.21 
to 119.2 + 10.03 cm/s, ACK (min) from 48.5 = 9.76 up to 52.1 ± 10.95 cm/s, ASK 
(mean) from 69.6 ± 8.45 to 74.1—11 × 57 cm/s, and hemisphere asymmetry ASA 
(mean) from 24.9 ± 9.51 up to 33.9 ± 10.51 with LC of classes A and C, respectively. 
At the same time, it should be noted that there is a rather clear correlation between 
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the stages of HE and hemisphere asymmetry of blood flow (r = 0.495). So, with 
increasing stage of HE, hemispheric asymmetry of blood flow along the MCA 
increases, caused, in our opinion, on the one hand by atherosclerosis, on the other 
by the lability of vascular resistance due to vasoconstrictive substances (nitric 
oxide, endothelin-1), whose concentration in the blood often increases with LC and 
atherosclerosis, which has been confirmed elsewhere [26, 27]. At the same time, 
the co-dependent indicators of vascular resistance had a clear downward trend 
depending on the degree of compensation of the LC. The dynamics of the statistical 
significance of this parameter in comparison with the norm for RI became reliable 
from p = 0.245844 to p = 0.002776 and PI from 0.071383 to 0.012336 with LC of 
classes A and C, respectively.
When conducting a comparative analysis of the blood flow velocity in MCA, 
two types of blood flow were identified—hypokinetic and hyperkinetic. Thus, with 
class C LC, in 21.4% of cases, the hyperkinetic type of blood flow was observed 
and which probably had a compensatory mechanism. In LC, damage occurs to 
the endothelial cells of the hepatic sinusoids, and the latter leads to a significant 
increase in the level of endothelin. With liver damage and the development of portal 
hypertension, the production of intrahepatic nitric oxide decreases, which leads to 
its imbalance. It should be noted that the known mechanisms of participation of 
endothelial dysfunction can be distinguished by the suppression of the excretion or 
inactivation of endothelial NO synthase and a decrease in the synthesis of NO, due 
to an increase in the level of cytokines and TNF-a, which suppress the synthesis of 
nitric oxide. During the formation of portal hypertension, the process of separa-
tion of the organ and the general blood flow is observed due to the development of 
an imbalance between vasodilating and vasoconstrictive substances. The release 
of vasoactive substances (histamine, serotonin), circulating vasodilators into the 
blood from damaged hepatocytes, leads to generalized vasodilation and a decrease 
in vascular resistance, which was confirmed in [28–31].
The data obtained by us indicate disorders in endothelium-dependent vasodila-
tion and the vasomotor function of the endothelium in LC at various stages of 
compensation and are to a certain extent confirmed in [32–36]. Hemodynamics 
in the brain at a constant level was possible due to the normal functioning of the 
autoregulation mechanism, which ensured an unchanged level of the cerebral blood 
flow in the form of vasodilatation or vasoconstriction. At the same time, in the 
beyond vasodilation, the phenomenon of “sausage string” with segmental dilatation 
of arterioles may occur, against the background of which there is a danger of blood 
breakthrough into the brain tissue and the development of acute disorders of cere-
bral circulation. In the prospective observation, the autopsy material of the brain 
served as confirmation of this phenomenon and the development of dyscirculatory 
disorders from minimal to irreversible in LC.
6. Conclusion
Chronic hepatic encephalopathy due to LC with a frequency of up to 75% of 
cases can occur in comorbidity with dyscirculatory disorders from minimal to 
irreversible, which aggravates the clinical course of hepatic encephalopathy.
The effect of dyscirculatory disorders on the clinical course of the stages of 
hepatic encephalopathy is ambiguous. The minimal effect is observed at stage I of 
hepatic encephalopathy, the maximum at hepatic encephalopathy of stage III in 
comorbidity with the stages of dyscirculatory encephalopathy. The degree of cogni-
tive and dyscirculatory disorders is interrelated with the stages of compensation for 
cirrhosis of the liver. With dyscirculatory disorders and a decrease in the stage of 
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